These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

18 related articles for article (PubMed ID: 4007625)

  • 1. Demonstration of effectiveness and tolerability of terconazole 80-mg vaginal suppositories (3 days) versus terconazole 240-mg vaginal suppositories (1 day) versus clotrimazole 200-mg vaginal tablets (3 days) in non-pregnant women with vulvovaginal candidosis.
    Loendersloot EW
    Gynakol Rundsch; 1985; 25 Suppl 1():99-104. PubMed ID: 4007627
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative double-blind evaluation of the efficacy and tolerability of terconazole 240-mg suppository (1 day) and 80-mg suppositories (3 days) versus clotrimazole 200-mg (3 days) in pregnant patients with vulvovaginal candidosis.
    Goormans E
    Gynakol Rundsch; 1985; 25 Suppl 1():74-82. PubMed ID: 3891540
    [No Abstract]   [Full Text] [Related]  

  • 3. One-day treatment of vaginal candidosis: comparison of terconazole 240-mg suppository with clotrimazole 500-mg vaginal tablet.
    Grice G; Spencer RC; Steele CE; Kinghorn GR
    Gynakol Rundsch; 1985; 25 Suppl 1():83-9. PubMed ID: 3891541
    [No Abstract]   [Full Text] [Related]  

  • 4. Terconazole 0.8% vaginal cream (5 days) versus clotrimazole 1% (6 days): efficacy and tolerability in an open study.
    Siedentopf HG
    Gynakol Rundsch; 1985; 25 Suppl 1():33-41. PubMed ID: 4007622
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of terconazole and clotrimazole vaginal tablets in the treatment of vulvovaginal candidosis.
    Kjaeldgaard A
    Pharmatherapeutica; 1986; 4(8):525-31. PubMed ID: 3520601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative open evaluation of efficacy and tolerability of terconazole 0.8% cream in a 5-day regimen versus clotrimazole 100-mg tablets in a 6-day regimen.
    Wesel S; Benijts G; Ubachs JM; Dogniez B
    Gynakol Rundsch; 1985; 25 Suppl 1():67-73. PubMed ID: 4007625
    [No Abstract]   [Full Text] [Related]  

  • 7. Drugs for treatment of vulvovaginal candidiasis: comparative efficacy of agents and regimens.
    Doering PL; Santiago TM
    DICP; 1990 Nov; 24(11):1078-83. PubMed ID: 2275233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terconazole--a new antifungal agent for vulvovaginal candidiasis.
    Weisberg M
    Clin Ther; 1989; 11(5):659-68. PubMed ID: 2680088
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.